TY - JOUR
T1 - Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition
AU - Storch, Eric A.
AU - McGuire, Joseph F.
AU - Wu, Monica S.
AU - Hamblin, Rebecca
AU - McIngvale, Elizabeth
AU - Cepeda, Sandra L.
AU - Schneider, Sophie C.
AU - Rufino, Katrina A.
AU - Rasmussen, Steven A.
AU - Price, Lawrence H.
AU - Goodman, Wayne K.
N1 - Funding Information:
Disclosure: Dr. Storch has received research support from the National Institutes of Health (NIH), the Red Cross, the Greater Houston Community Foundation, the Rebuild Texas Foundation, Mental Health America–Houston, and the Texas Education Coordinating Board. He has served as a consultant for Levo Pharmaceuticals. He has received book royalties from Elsevier, Lawrence Erlbaum, Springer, Jessica Kingsley, and the American Psychological Association. Dr. McGuire has received research support from the Tourette Association of America, the American Academy of Neurology, and the American Brain Foundation. He has served as a consultant for Bracket has received book royalties from Elsevier. Dr. Wu has received grant or research support from the NIMH. Dr. McIngvale has received funding from the Red Cross. Dr. Goodman has received research support from the NIH, Biohaven, and the Simons Foundation. He has served as a consultant for Biohaven. Drs. Hamblin, Schneider, Rufino, Rasmussen, and Price and Ms. Cepeda report no biomedical financial interests or potential conflicts of interest.
Publisher Copyright:
© 2018 American Academy of Child and Adolescent Psychiatry
PY - 2019/1
Y1 - 2019/1
N2 - Objective: To develop and examine the psychometric properties of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition (CY-BOCS-II) in children and adolescents with obsessive-compulsive disorder (OCD). Method: Youth with OCD (N = 102; age range 7–17 years), who were seeking treatment from 1 of 2 specialty OCD treatment centers, participated in the study. The CY-BOCS-II was administered at an initial assessment, and measures of OCD symptom severity, anxiety and depressive symptoms, behavioral and emotional problems, and global functioning were administered. Inter-rater and test-retest reliabilities were assessed on a subsample of participants (n = 50 and n = 31, respectively) approximately 1 week after intial assessment. Results: The CY-BOCS-II demonstrated moderate-to-strong internal consistency (α = 0.75–0.88) and excellent inter-rater (intraclass correlation coefficient = 0.86–0.92) and test-retest (intraclass correlation coefficient = 0.95–0.98) reliabilities across all scales. Construct validity was supported by strong correlations with clinician-rated measures of OCD symptom severity and moderate correlations with measures of anxiety symptoms. Exploratory factor analysis showed a 2-factor structure, which was generally inconsistent with its adult counterpart, the Yale-Brown Obsessive-Compulsive Scale Second Edition. Conclusion: Initial findings support the CY-BOCS-II as a reliable and valid measure of obsessive-compulsive symptoms in youth.
AB - Objective: To develop and examine the psychometric properties of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition (CY-BOCS-II) in children and adolescents with obsessive-compulsive disorder (OCD). Method: Youth with OCD (N = 102; age range 7–17 years), who were seeking treatment from 1 of 2 specialty OCD treatment centers, participated in the study. The CY-BOCS-II was administered at an initial assessment, and measures of OCD symptom severity, anxiety and depressive symptoms, behavioral and emotional problems, and global functioning were administered. Inter-rater and test-retest reliabilities were assessed on a subsample of participants (n = 50 and n = 31, respectively) approximately 1 week after intial assessment. Results: The CY-BOCS-II demonstrated moderate-to-strong internal consistency (α = 0.75–0.88) and excellent inter-rater (intraclass correlation coefficient = 0.86–0.92) and test-retest (intraclass correlation coefficient = 0.95–0.98) reliabilities across all scales. Construct validity was supported by strong correlations with clinician-rated measures of OCD symptom severity and moderate correlations with measures of anxiety symptoms. Exploratory factor analysis showed a 2-factor structure, which was generally inconsistent with its adult counterpart, the Yale-Brown Obsessive-Compulsive Scale Second Edition. Conclusion: Initial findings support the CY-BOCS-II as a reliable and valid measure of obsessive-compulsive symptoms in youth.
KW - Children's Yale-Brown Obsessive-Compulsive Scale
KW - assessment
KW - obsessive-compulsive disorder
KW - treatment
KW - validity
UR - http://www.scopus.com/inward/record.url?scp=85058566073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058566073&partnerID=8YFLogxK
U2 - 10.1016/j.jaac.2018.05.029
DO - 10.1016/j.jaac.2018.05.029
M3 - Article
C2 - 30577944
AN - SCOPUS:85058566073
SN - 0890-8567
VL - 58
SP - 92
EP - 98
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
IS - 1
ER -